Abstract
In attempt to develop a drug delivery system using serum albumin microspheres, bovine serum albumin microspheres containing antitumor agent, cytarabine, were prepared. The shape, surface characteristics, size distribution, behavior ofin vitro distribution, drug release behavior, and degradation of albumin microspheres in animal liver tissue homogenate and proteolytic enzyme were investigated.
The shape of albumin microspheres was spherical and the surface was smooth and compact. The size distribution of the albumin microspheres was affected by dispersion forces during emulsification and albumin concentration. Distribution of albumin microspheres after intravenous administration in rabbit was achieved immediately.In vitro, albumin microsphere matrix was so hard that it retained most of cytarabine except initial burst during the first 10 minutes, and the level of drug release during the initial burst was affected by heating temperature, drug/albumin concentration ratio and size distribution. After drug release test, the morphology of albumin microspheres was not changed. Albumin microsphere matrix was degraded by the rabbit liver tissue homogenate and proteolytic enzyme. The degree of degradation was affected by heating temperature.
Similar content being viewed by others
Literature Cited
Zolle, I., Rhodes, B. A. and Wagner, Jr., N. H.: Preparation of metabolizable radioactive human serum microspheres for studies of the circulation.Int. J. Appl. Rad. Iso.,21, 155 (1970).
Cornell, R. P. and Saba, T. M.: Humoral control of colloid clearance by reticuloendothelial system in dogs.Am. J. Physiol.,225, 1300 (1973).
Scheffel, U., Rhodes, B. A., Natarajan, J. K. and Wagner, Jr., N. H.: Albumin microspheres for study of the reticuloendothelial system.J. Nucl. Med.,13, 498 (1972).
Kramer, P. A.: Albumin microspheres as vehicles for achieving specificity in drug delivery.J. Pharm. Sci.,63, 1646 (1974).
Kramer, P. A. and Burnstein, T.: Phagocytosis of microspheres containing an anticancer agent by tumor cellsin vitro.Life Sci.,19, 515 (1976).
Sugibayashi, K., Morimoto, Y., Nadai, T. and Kato, Y.: Drug-carrier property of albumin microspheres in chemotherapy. II. Preparation and tissue distribution in mice of microsphere-entrapped 5-Fluorouracil.Chem. Pharm. Bull.,27, 204 (1979).
Sugibayashi, K., Akimoto, M., Morimoto, Y., Nadai, T. and Kato, Y., Drug-carrier property of albumin microspheres in chemotherapy. III. Effect of microsphere-entrapped 5-fluorouracil on Ehrlich ascites carcinoma in mice.J. Pharm. Dyn.,2, 350 (1979).
Morimoto, Y., Akimoto, M., Sugibayashi, K., Nadai, T. and Kato, Y.: Drug-carrier property of albumin microspheres in chemotherapy. IV. Antitumor effect of single-shoot or multiple-shot administration of microsphere-entrapped 5-flluorouracil on Ehrlich Ascites or solid tumor in mice.Chem. Pharm. Bull.,28, 3087 (1980).
Morimoto, Y., Sugibayashi, K. and Kato, Y., Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin on liver metastasis of AH 7974 cells in rats.Chem. Pharm. Bull.,29, 1433 (1981).
Widder, K. J. and Senyei, A. E.: Intravascularly-administrable, magnetically-localizable carrier.U. S. pat. 4, 247, 406 (1981).
Widder, K. J., Senyei, A. E. and Ranney, D. F.:In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. Cancer Research,40, 3512 (1980).
Widder, K. J., Morris, R. M., Poore, G., Howard, Jr., D. and Senyei, A. E.: Tumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin.Proc. Natl. Acad. Sci., USA,78, 579 (1981).
Fushimi, H., Shibata, M. and Tarui, S.: Glycosidase activities in the liver and kidney of hereditary diabetic mice.J. Biochem.,87, 941 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, CK., Jeong, E.J., Yang, J.S. et al. Development of specific organ-targeting drug delivery system I: Physico-pharmaceutical characteristics of thermally denatured albumin microspheres containing cytarabine. Arch. Pharm. Res. 8, 159–168 (1985). https://doi.org/10.1007/BF02857041
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02857041